Galina Gheihman1, Camilla Zimmermann2,3,4, Amy Deckert2, Peter Fitzgerald2,5, Ashley Mischitelle2, Anne Rydall2, Aaron Schimmer3,6,7, Lucia Gagliese2,3,5,8,9,10, Chris Lo2,5, Gary Rodin2,3,5. 1. Faculty of Arts & Science, University of Toronto, Toronto, Canada. 2. Department of Supportive Care, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada. 3. Campbell Family Cancer Research Institute, Ontario Cancer Institute, University Health Network, Toronto, Canada. 4. Department of Medicine, University of Toronto, Toronto, Canada. 5. Department of Psychiatry, University of Toronto, Toronto, Canada. 6. Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada. 7. Department of Medical Biophysics, University of Toronto, Toronto, Canada. 8. School of Kinesiology and Health Science, York University, Toronto, Canada. 9. Department of Anesthesia, University of Toronto, Toronto, Canada. 10. Department of Anesthesia, University Health Network, Toronto, Canada.
Abstract
OBJECTIVE: Acute leukemia (AL) is a life-threatening cancer associated with substantial morbidity and mortality, particularly in older adults. Given that there has been little research on the psychological impact of such malignancies with acute onset, we assessed the prevalence and correlates of depression and hopelessness in patients with AL. METHODS: Three hundred forty-one participants were recruited within 1 month of diagnosis or relapse and completed the Beck Depression Inventory-II (BDI-II), Beck Hopelessness Scale (BHS), Memorial Symptom Assessment Scale, and other psychosocial measures. Multivariate regression analyses identified correlates of depression and hopelessness. RESULTS: 17.8% reported clinically significant depressive symptoms (BDI-II ≥ 15), 40.4% of which were in the moderate-severe range (BDI-II ≥ 20). 8.5% reported significant symptoms of hopelessness (BHS ≥ 8). Depression was associated with greater physical symptom burden (adjusted R(2) = 48.4%), while hopelessness was associated with older age and lower self-esteem (adjusted R(2) = 45.4%). Both were associated with poorer spiritual well-being. CONCLUSIONS: Clinically significant depressive symptoms were common early in the course of AL and related to physical symptom burden. Hopelessness was less common and associated with older age and lower self-esteem. The results suggest that whereas depression in AL may be related to disease burden, the preservation of hope may be linked to individual resilience, life stage, and realistic prognosis.
OBJECTIVE:Acute leukemia (AL) is a life-threatening cancer associated with substantial morbidity and mortality, particularly in older adults. Given that there has been little research on the psychological impact of such malignancies with acute onset, we assessed the prevalence and correlates of depression and hopelessness in patients with AL. METHODS: Three hundred forty-one participants were recruited within 1 month of diagnosis or relapse and completed the Beck Depression Inventory-II (BDI-II), Beck Hopelessness Scale (BHS), Memorial Symptom Assessment Scale, and other psychosocial measures. Multivariate regression analyses identified correlates of depression and hopelessness. RESULTS: 17.8% reported clinically significant depressive symptoms (BDI-II ≥ 15), 40.4% of which were in the moderate-severe range (BDI-II ≥ 20). 8.5% reported significant symptoms of hopelessness (BHS ≥ 8). Depression was associated with greater physical symptom burden (adjusted R(2) = 48.4%), while hopelessness was associated with older age and lower self-esteem (adjusted R(2) = 45.4%). Both were associated with poorer spiritual well-being. CONCLUSIONS: Clinically significant depressive symptoms were common early in the course of AL and related to physical symptom burden. Hopelessness was less common and associated with older age and lower self-esteem. The results suggest that whereas depression in AL may be related to disease burden, the preservation of hope may be linked to individual resilience, life stage, and realistic prognosis.
Authors: Thomas W LeBlanc; Christine S Ritchie; Fred Friedman; Janet Bull; Jean S Kutner; Kimberly S Johnson; Arif H Kamal Journal: J Pain Symptom Manage Date: 2016-11-01 Impact factor: 3.612
Authors: Ryan D Nipp; Areej El-Jawahri; Sara M D'Arpino; Andy Chan; Charn-Xin Fuh; P Connor Johnson; Daniel E Lage; Risa L Wong; William F Pirl; Lara Traeger; Barbara J Cashavelly; Vicki A Jackson; David P Ryan; Ephraim P Hochberg; Jennifer S Temel; Joseph A Greer Journal: Cancer Date: 2018-06-15 Impact factor: 6.860
Authors: Kristina Holmegaard Nørskov; Dorthe Overgaard; Jannie Boesen; Anne Struer; Sarah Elke Weber Due El-Azem; Anders Tolver; Kirsten Lomborg; Lars Kjeldsen; Mary Jarden Journal: Support Care Cancer Date: 2020-10-13 Impact factor: 3.603